Sports Medicine
ORTHOVISC™ High Molecular Weight Hyaluronan
Product Codes:
277500Sports Medicine
ORTHOVISC™ High Molecular Weight Hyaluronan
Product Codes:
277500ORTHOVISC™ High Molecular Weight Hyaluronan is a non-avian sourced hyaluronic acid injection therapy that has up to six months of clinically proven efficacy with 3 or 4 injections.1
IMAGES
Features & Benefits
High HA Content
Provides more HA to the joint than any other multi-injection product.1 -2
Improvement in Knee Pain
Improvement in pain and function that lasts up to 6 months.1
Safety Profile
Similar to saline demonstrated in clinical trials even during retreatment.1
Product Resources
Clinical Resources
-
Instructions For Use
-
ORTHOVISC™ HCP Brochure
References
- ORTHOVISC [package insert]. Bedford, MA: Anika Therapeutics, Inc., 2020
- Euflexxa [package insert]. Parsippany, NJ: Ferring Pharmaceuticals Inc., 2016
- Gelsyn-3 [package insert]. Durham, NC: Bioventus; 2016
- Synvisc (Hyalgan G-F 20) [package insert]. Ridgefield, NJ: Genzyme Biosurgery; 2020
- Hyalgan [package insert]. Parsippany, NJ Fidia Pharma USA Inc.; 2014
- Supartz FX [package insert]. Durham, NC: Bioventus; 2015
- TriVisc [package insert]. Doylestown, PA: OrthogenRx, Inc.; 2017
- Hymovis [package insert]. Parsippany, NJ Fidia Pharma USA Inc.; 2015
- GenVisc 850 [package insert]. Doylestown, PA: OrthogenRx, Inc.; 2015
- Visco-3 [package insert]. Tokyo, Japan: Seikagaku Corp.; 2017
ORTHOVISC™ High Molecular Weight Hyaluronan is indicated in the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy and to simple analgesics, e.g., acetaminophen. In clinical studies, the most commonly reported adverse events were arthralgia, back pain, and headache. Other side effects included local injection site adverse events. ORTHOVISC™ is contraindicated in patients with known hypersensitivity to hyaluronate formulations or known hypersensitivity (allergy) to gram positive bacterial proteins. ORTHOVISC™ should not be injected in patients with infections or skin diseases in the area of the injection site. Intra-articular injection of sodium hyaluronate preparations has occasionally been associated with allergic/anaphylactic reactions and transient hypotension, which have generally resolved spontaneously or after conservative treatment. ORTHOVISC™ is manufactured by and is a registered trademark of Anika Therapeutics, Inc.
All medical devices have associated risks. Please refer to the package insert and other labeling for a complete list of indications, contraindications, precautions and warnings. For further information on DePuy Synthes Products, please contact your local DePuy Synthes Representative
Please refer to the Instructions For Use for a complete list of indications, contraindications, warnings and precautions. The third-party trademarks used herein are the trademarks of their respective owners.
233804-221128
© DePuy Synthes 2022. All Rights Reserved. This site is published by the DePuy Synthes Companies, which are solely responsible for its content. This site is governed solely by applicable U.S. laws and governmental regulations. This site is for visitors from the United States. The third party trademarks used herein are the trademarks of their respective owners.